Key result
In spontaneously hypertensive rats, relaxant responses to acetylcholine were attenuated despite increased eNOS expression, indicating dysregulation of antioxidant enzymes causes endothelial dysfunction.
Why the study?
Does pretreatment with antioxidant enzyme modulators improve endothelial dysfunction in spontaneously hypertensive rats?
Does pretreatment with antioxidant enzyme modulators improve endothelial dysfunction in spontaneously hypertensive rats?
Dysregulation of antioxidant enzymes, particularly catalase, contributes to endothelial dysfunction in genetic hypertension, suggesting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Antioxidant enzyme dysregulation may drive endothelial dysfunction in genetic hypertension; hypothesis-generating for therapeutic targeting in animal models only.
OBJECTIVE: Enhanced oxidative stress is involved in mediating the endothelial dysfunction associated with hypertension. The aim of this study was to investigate the relative contributions of pro-oxidant and anti-oxidant enzymes to the pathogenesis of endothelial dysfunction in genetic hypertension. METHODS: Dilator responses to endothelium-dependent and endothelium-independent agents such as acetylcholine (ACh) and sodium nitroprusside were measured in the thoracic aortas of 28-week-old spontaneously hypertensive rats (SHR) and their matched normotensive counterparts, Wistar Kyoto rats (WKY). The activity and expression (mRNA and protein levels) of endothelial nitric oxide synthase (eNOS), p22-phox, a membrane-bound component of NAD(P)H oxidase, and antioxidant enzymes, namely, superoxide dismutases (CuZn- and Mn-SOD), catalase and glutathione peroxidase (GPx), were also investigated in aortic rings. RESULTS: Relaxant responses to ACh were attenuated in phenylephrine-precontracted SHR aortic rings, despite a 2-fold increase in eNOS expression and activity. Although the activity and/or expression of SODs, NAD(P)H oxidase (p22-phox) and GPx were elevated in SHR aorta, catalase activity and expression remained unchanged compared to WKY. Pretreatment of SHR aortic rings with the inhibitor of xanthine oxidase, allopurinol, and the inhibitor of cyclooxygenase, indomethacin, significantly potentiated ACh-induced relaxation. Pretreatment of SHR rings with catalase and Tiron, a superoxide anion (O(2)(-)) scavenger, increased the relaxant responses to the levels observed in WKY rings whereas pyrogallol, a O(2)(-)-generator, abolished relaxant responses to ACh. CONCLUSION: These data demonstrate that dysregulation of several enzymes, resulting in oxidative stress, contributes to the pathogenesis of endothelial dysfunction in SHR and indicate that the antioxidant enzyme catalase is of particular importance in the reversal of this defect.
No takes yet. Share an insight, caveat, or question.
Ülker et al. (2003) studied Genetic hypertension. Genetic hypertension vs. Normotensive Wistar Kyoto rats (WKY) was evaluated on Dilator responses to endothelium-dependent and endothelium-independent agents. In spontaneously hypertensive rats, relaxant responses to acetylcholine were attenuated despite increased eNOS expression, indicating dysregulation of antioxidant enzymes causes endothelial dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: